Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -203,417 | -166,247 | -196,767 | -108,621 | -66,233 |
| Depreciation Amortization | 27,289 | 29,640 | 23,438 | 24,905 | 17,802 |
| Accounts receivable | -8,704 | -4,567 | 1,574 | 3,064 | 5,515 |
| Accounts payable and accrued liabilities | -450 | -5,646 | -2,151 | 4,770 | 3,732 |
| Other Working Capital | -52,073 | -12,741 | 70,176 | 16,095 | 38,366 |
| Other Operating Activity | 65,301 | 17,444 | -63,893 | -19,752 | -6,229 |
| Operating Cash Flow | $-172,054 | $-142,117 | $-167,623 | $-79,539 | $-7,047 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,959 | -12,538 | -17,351 | -38,875 | -49,391 |
| Purchase Of Investment | -236,548 | -148,642 | -554,239 | -702,885 | -1,255,897 |
| Sale Of Investment | 243,410 | 292,351 | 593,998 | 727,582 | 1,176,143 |
| Other Investing Activity | 8,365 | -23,786 | 97,177 | -1,784 | -15,942 |
| Investing Cash Flow | $-1,732 | $107,385 | $119,585 | $-15,962 | $-145,087 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 27,460 | 5,000 | N/A |
| Debt Repayment | N/A | -12,563 | -1,951 | -3,986 | -23,317 |
| Common Stock Issued | 197,591 | 8,742 | 11,959 | 13,327 | 18,626 |
| Other Financing Activity | -135 | -4,805 | 0 | -499 | -318 |
| Financing Cash Flow | $197,456 | $-8,626 | $37,468 | $13,842 | $-5,009 |
| Exchange Rate Effect | -631 | 205 | 631 | 552 | -311 |
| Beginning Cash Position | 55,006 | 98,159 | 108,098 | 189,205 | 346,659 |
| End Cash Position | 78,045 | 55,006 | 98,159 | 108,098 | 189,205 |
| Net Cash Flow | $23,039 | $-43,153 | $-9,939 | $-81,107 | $-157,454 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,054 | -142,117 | -167,623 | -79,539 | -7,047 |
| Capital Expenditure | -16,959 | -12,538 | -17,351 | -38,875 | -49,391 |
| Free Cash Flow | -189,013 | -154,655 | -184,974 | -118,414 | -56,438 |